A promising molecule is only the beginning. The real challenge is developing a process that remains reliable as programs advance from laboratory development to pilot production and ultimately commercial manufacturing. That requires balancing chemistry, engineering, analytical science, and manufacturing expertise from the earliest stages. Sponsors that integrate these disciplines early are often better equipped to reduce development risk, avoid unnecessary process changes, and accelerate the path to market. Olon USA applies decades of API expertise to help innovative molecules become commercially viable manufacturing processes, not just successful laboratory projects. Click here to learn how that experience can make the difference for your next molecule: https://lnkd.in/gbDRhprX #DrugSubstance #API #ProcessChemistry #Commercialization #CDMO #LifeSciences #PharmaceuticalDevelopment
About us
Who we are: On June 9, 2017, Olon S.p.A., a leading Active Pharmaceutical Ingredients (API) contract development and manufacturing organization (CDMO) and Generics supplier, announced the acquisition of Ricerca Biosciences’ Chemical Division of the contract research (CRO) and CDMO based in Concord, Ohio, USA. This acquisition strengthens the service offering of Olon for the pharmaceutical and biotech industry and benefits Ricerca Biosciences' customer base by providing large-scale manufacturing capabilities in Europe. Olon USA is a US-based CDMO supporting the development and manufacture of APIs and performance materials in support clinical supply, market development and commercial distribution. Olon USA’s extensive process/synthetic chemistry, analytical chemistry and engineering expertise provides a synergy that excels at first-time scale-ups and subsequent development of safe, reliable, robust and cost-effective manufacturing processes. For more than 25 years, Olon USA has a record of on-time delivery and quality, providing comprehensive support and problem solving for successful development, scale-up and process-optimized manufacture of pharmaceutical ingredients. Company Details Website: http://www.olon-usa.com Location: Concord, OH Florham Park, NJ
- Website
-
http://www.olon-usa.com
External link for Olon USA
- Industry
- Pharmaceutical Manufacturing
- Company size
- 51-200 employees
- Headquarters
- Concord, OH
- Type
- Privately Held
- Founded
- 2017
- Specialties
- Chemical Development, Synthetic Chemistry, Analytical Services, CRO, CDMO, API, GMP, GLP, Drug Substance, and generic
Locations
-
Primary
Get directions
7528 Auburn Rd
Concord, OH 44077, US
-
Get directions
100 Campus Drive
Florham Park, NJ 07932, US
Employees at Olon USA
Updates
-
Olon USA’s global leadership in Milan, Italy has officially announced the completion of a major expansion at its Concord, Ohio facility, marking a significant step forward for their U.S. manufacturing capabilities and its integrated global API network. For Olon USA, this news represents much more than additional production capacity. It signals the continued evolution of Concord from a site historically known for R&D, chemical synthesis, process development, and early-stage manufacturing into something much broader: a fully integrated U.S. development and commercial manufacturing hub backed by the strength of Olon’s global network. That distinction matters. Today’s pharmaceutical and biotechnology companies are asking different questions than they were just a few years ago. They are not only evaluating technical capability or available capacity. They are asking where their APIs will be manufactured, how resilient their supply chain will be, and whether their CDMO partner can support them from early development through commercial production without unnecessary handoffs or disruption. With the completion of this expansion, Olon USA is positioned to answer those questions with greater confidence than ever before. Click here to learn more: https://lnkd.in/gm6tbHFd
-
We are excited to announce the completion of a major expansion at our Olon USA Concord, Ohio facility, marking a significant step forward for Olon's manufacturing capabilities and our integrated global API network!
Olon has completed a major expansion of its Concord, Ohio facility, further strengthening its role within the Group's global manufacturing network. The investment doubles the site's manufacturing capacity, enhances its integrated development and commercial manufacturing capabilities, and reinforces Olon's ability to support pharmaceutical and biotechnology companies across the full product lifecycle. Olon USA Read the full press release: https://lnkd.in/dWxAWUXX #Olon #PharmaceuticalManufacturing #API
-
-
This Independence Day, as America celebrates 250 years of innovation, resilience, and progress, we reflect on the role manufacturing continues to play in shaping the future. At Olon USA, we're proud to contribute to that future through the development and manufacture of active pharmaceutical ingredients that help support critical therapies around the world. As part of a global organization with roots in Italy and a growing presence in the United States, we believe innovation is strengthened through collaboration, investment, and a shared commitment to advancing science. From our team in Ohio to our colleagues across the globe, we wish everyone a safe and meaningful Fourth of July as we celebrate America's 250th anniversary. #America250 #Manufacturing #PharmaceuticalManufacturing #LifeSciences
-
-
Funding constraints. Supply chain uncertainty. Growing demand for domestic manufacturing. These factors are reshaping how biotech and pharmaceutical companies evaluate development and manufacturing partners in 2026. As industry leaders gather at BIO International Conference, conversations are increasingly focused on reducing risk, strengthening supply chains, and creating scalable paths from development through commercialization. Learn how flexible manufacturing strategies, global collaboration, and U.S.-based capabilities are helping sponsors navigate today's development environment. Members of Olon's business development and technical leadership team, including Andrea Conforto, VP Biotech CDMO Olon & Olon France; Amaia Mendivil, Biotech CDMO Business Development Manager; Dr. Amit Kumar Rai, CMPP, Senior BD Sales and Marketing Olon France; and Laura Milbrandt, Senior Director of Business Development, will be available at Booth 4751 to discuss upcoming development and manufacturing programs. Click here to learn more and schedule your meeting at BIO in advance: https://lnkd.in/gh5r7QzY #BIO2026 #Biotech #PharmaceuticalManufacturing #CDMO #APIDevelopment #DrugDevelopment #SupplyChain #ManufacturingStrategy #LifeSciences
-
Big news for Northeast Ohio! Olon USA’s continued investment in its Concord facility is more than an expansion project, it’s an investment in people, careers, and the future of our region. As the pharmaceutical and life sciences industries continue to grow, so does the need for highly skilled talent, advanced manufacturing capabilities, and opportunities for local communities to thrive. We’re proud to be part of a community that continues to attract growth, foster innovation, and support high-quality careers. Click here to read more: https://lnkd.in/gAsCxAe5 #OlonUSA #PharmaceuticalManufacturing #LifeSciences #EconomicDevelopment #ManufacturingJobs #NortheastOhio
-
Excellent first day meetings at CPHi Americas here in Philadelphia, PA followed by a team dinner with the PPP and CDMO BD teams at one of our favorite local spots. Heading into day 2 with an early start! #cphi Robert P. Tim MorganNerissa Chu-A-KongLael CheungLaura MilbrandtBea OngwongMRINALINI ARORALoredana PintoSharmila K.Nureddin Khaled Mansour
-
-
Early API decisions can determine the success or failure of a development program. Route selection, process chemistry, scalability, analytical planning, and manufacturing readiness all influence future timelines, regulatory outcomes, and overall program costs. When these decisions are made with long-term goals in mind, sponsors can reduce development risk, avoid costly rework, and improve tech transfer outcomes later in the program. At Olon USA, API development is approached as part of a broader CMC strategy from the start, helping create a more efficient path from early development through commercialization. Click here to read more: https://lnkd.in/g-AcsZbC #APIDevelopment #CMC #DrugDevelopment #PharmaceuticalManufacturing #CDMO #ProcessChemistry #Biotech #LifeSciences #OlonUSA
-
We're #hiring a new Quality Compliance Professional - Production in Painesville, Ohio. Apply today or share this post with your network.
-
At Olon USA we are always trying to up our game, not only in science but in Strategic Skills as well. Earlier this week we had Sarah Eppink, MOD, BCC join us for a lunch and learn session, "Impactful Feedback Conversations." Learning how give, and to receive meaningful feedback so we can grow as individuals and as an organization. Thank you Sarah from the Olon USA Team we look forward to the next one in July. Robert P.
-